List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 64 studies with search of: "Glucagon"
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Recruiting GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
Condition: Type 2 Diabetes Mellitus
Intervention: Biological: Glucose-dependent insulinotropic polypeptide (GIP), glucagon-like peptide-1 (GLP-1) and glucagon-like peptide-2 (GLP-2)
2 Completed Pharmacokinetics (PK) and Pharmacodynamics (PD) of Mayne Glucagon for Injection Compared With Glucagen® (Novo Nordisk) in Healthy Volunteers
Condition: Hypoglycemia
Interventions: Drug: Glucagen;   Drug: Mayne Glucagon
3 Recruiting Sensor-Augmented Insulin Delivery: Insulin Plus Glucagon vs Insulin Alone
Condition: Type 1 Diabetes
Interventions: Device: insulin alone;   Device: insulin plus glucagon
4 Recruiting A Phase 1 Study to Evaluate the Safety and Tolerability of GSK1362885 in Healthy Normal Subjects
Conditions: Healthy Subjects;   Healthy Volunteer
Interventions: Drug: Glucagon;   Drug: GSK1362885;   Drug: GSK1362885;   Drug: Glucagon + GSK1362885
5 Recruiting Glucagon in the Treatment of Hypoglycemia in Newborn Infants of Diabetic Mothers
Condition: Hypoglycemia
Intervention: Drug: glucagon
6 Completed To Evaluate the Response to Glucagon During Hypoglycemia
Condition: Type 2 Diabetes
Interventions: Drug: AZD1656;   Drug: Glucagon
7 Completed The Role of Amylin and Glucagon in T1DM
Condition: Type 1 Diabetes
Intervention: Drug: Pramlintide and glucagon
8 Completed A Study of the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Activity of Very Low Dose-Glucagon in Subjects With Type 1 Diabetes Mellitus
Condition: Type 1 Diabetes
Intervention: Drug: very low dose (VLD) glucagon
9 Not yet recruiting A Pilot Study to Evaluate the Glucagon-Like Peptide 1 Response to the Challenge of Mixed Meals in Chinese Subjects
Condition: Healthy
Intervention:
10 Enrolling by invitation Influence of Glucagon Inhibition in Relation to the Anti-Diabetic Effect of Glucagon-Like Peptide-1 (GLP-1) in Patients With Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Intervention: Other: Infusion of native hormones from the pancreas and gut (GLP-1)
11 Recruiting Intravenous-Morphine and Glucagon-Usage Enhanced MR Cholangiography
Condition: Liver Disease
Intervention: Drug: morphine and glucagon
12 Completed The Effects of GIP and GLP-2 on the Secretion of Glucagon in Patients With Type 1 Diabetes
Condition: Diabetes Mellitus
Interventions: Other: GIP-infusion;   Other: Sodium-chloride;   Other: GLP-2 infusion
13 Recruiting Sulfonylurea Effects on Glucagon Regulation During Hypoglycemia in Type 1 DM
Condition: Diabetes Mellitus, Type 1
Interventions: Drug: glibenclamide;   Drug: placebo
14 Recruiting Plasma Determination of Glucagon-Like Peptide 2 as a Predictor of Recovery in Adults With Acute Intestinal Failure
Condition: Short Bowel Syndrome
Intervention:
15 Active, not recruiting Exploratory Study of Additional Use of Scopolamine Butylbromide, Glucagon or NPO-11 Following Single Dose of NPO-11 in Healthy Adult Men
Condition: Healthy
Interventions: Drug: NPO-11;   Drug: NPO-11;   Drug: NPO-11
16 Recruiting Effect of GLP-1 and GIP on Insulin Secretion in Type-1 Diabetes Mellitus
Condition: Type-1 Diabetes Mellitus
Interventions: Other: glucagon like peptide -1;   Other: NaCl;   Other: glucose dependent insulinotropic polypeptide
17 Recruiting Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
Condition: Type 2 Diabetes
Interventions: Drug: glucagon like peptide-1;   Drug: glucose control
18 Completed Near Normalisation of BG Improves the Potentiating Effect of GLP-1
Condition: Diabetes Mellitus Type 2
Interventions: Drug: glucagon-like peptide-1;   Drug: Saline
19 Enrolling by invitation The Efficacy of GLP - 1(7-36) Amide for Glycemic Control in Critically Ill Patients
Conditions: Critically Ill;   Hypoglycemia
Interventions: Drug: Glucagon-Like Peptide-1;   Drug: Saline
20 Completed Beta-Cell Function After Near-Normalisation of Blood Glucose
Condition: Type 2 Diabetes
Interventions: Drug: glucagon-like peptide-1,;   Drug: glucose dependent insulinotropic polypeptide;   Drug: Saline

Previous Page Studies Shown (1-20) Next Page (21-40)
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services